KNSA earnings: a positive outcome, +9.5%

On August 4, 2022, Kiniksa Pharmaceuticals International, plc reached its earnings. The result was a positive outcome, and the stock moved +9.5% in the window around the event. It had already run -11.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.